ALAMEDA, CA. —Emery Pharma, a privately owned full-service contract research laboratory, specializing in analytical, microbiology & cell biology testing, custom synthesis, and general R&D Support, today has announced that Ron Najafi, Ph.D., CEO of Emery Pharma, will be attending the 2017 American Association of Pharmaceutical Scientists Conference, held November 12-15, 2017 in San Diego, California. Dr. Najafi will be available to respond to questions and to participate in one-on-one meetings with attendees of the conference.
Event: 2017 AAPS Annual Meeting and Exposition Conference in San Diego, CA.
Date: November 12-15, 2017
Place: Booth Number:1150
To schedule a meeting with Dr. Najafi at AAPS event please contact:
We look forward to seeing you there!
About Emery Pharma
Emery Pharma is a GMP/GLP compliant, FDA registered contract research organization focused on supporting mid-size biotech, pharma with their pre-clinical development. The team at Emery Pharma is experienced in drug discovery/medicinal chemistry, method development (pharmaceutical and biological) and validation, dissolution testing, non-clinical dose formulation and analysis, pharmaceutical impurity isolation and characterization (ID), short/long-term stability testing, discovery modeling and testing, drug candidate selection, nutraceutical and natural products. Emery Pharma has significant expertise in complex NMR analysis, and offers GMP NMR. Additionally, Emery Pharma supports PK bioanalytical analysis of API and metabolites using LCMS/MS (triple quad). Emery Pharma prides itself in helping solve tough problems and adding value to the client’s projects.
Stay connected with Emery Pharma:
Contact us at: +1-510-899-8814 or 1-888-98-EMERY